K Keven
Overview
Explore the profile of K Keven including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
318
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dogan S, Celebi Z, Akturk S, Kutlay S, Tuzuner A, Keven K, et al.
Transplant Proc
. 2017 Mar;
49(3):532-536.
PMID: 28340828
Background: BK virus is the cause of nephropathy, which can progress to graft loss after kidney transplantation. In this study, we aimed to investigate the prevalence and risk factors of...
2.
Eyupoglu S, Eyupoglu D, Kendi-Celebi Z, Akturk S, Tuzuner A, Keven K, et al.
Transplant Proc
. 2017 Mar;
49(3):505-508.
PMID: 28340822
Background: Hyperuricemia is a common complication in renal transplant recipients. Recent studies have suggested that hyperuricemia may contribute to the deterioration of graft function. Methods: In this study, we aimed...
3.
Average Tacrolimus Trough Level in the First Month After Transplantation May Predict Acute Rejection
Akturk S, Erdogmus S, Kumru G, Elhan A, Sengul S, Tuzuner A, et al.
Transplant Proc
. 2017 Mar;
49(3):430-435.
PMID: 28340806
Background: Although tacrolimus is one of the essential drugs used for the prevention of rejection in kidney recipients, target trough levels are not well established. In this study, we aimed...
4.
Karakose S, Erdogmus S, Akturk S, Tuzuner A, Sengul S, Keven K
Transplant Proc
. 2017 Mar;
49(3):399-402.
PMID: 28340799
Background: Familial Mediterranean fever (FMF) is an autosomal-recessive autoinflammatory disorder manifested severely by systemic amyloidosis. It has been hypothesized that heterozygous carriers may also have susceptibility to certain symptoms or...
5.
Randall J, Keven K, Atli T, Ustun C
Bone Marrow Transplant
. 2015 Oct;
51(5):623-8.
PMID: 26457910
Allogeneic hematopoietic cell transplantation (alloHCT) may be the only curative option for some older adults with hematologic malignancies, and its associated risks of significant morbidity and mortality warrant a clear,...
6.
Mamatov E, Kocaay A, Koc M, Celebi Z, Sengul S, Keven K, et al.
Transplant Proc
. 2015 Aug;
47(6):1688-91.
PMID: 26293034
Background: Renal transplantation is the best choice for the treatment of dialysis patients with end-stage renal failure because it provides better quality of life and more life time. However, despite...
7.
Akturk S, Celebi Z, Erdogmus S, Kanmaz A, Yuce T, Sengul S, et al.
Transplant Proc
. 2015 Jun;
47(5):1442-4.
PMID: 26093738
Although pregnancy after kidney transplantation has been considered as high risk for maternal and fetal complications, it can be successful in properly selected patients. It is well known that pregnancy...
8.
Yalci A, Celebi Z, Ozbas B, Sengezer O, Unal H, Memikoglu K, et al.
Transplant Proc
. 2015 Jun;
47(5):1429-32.
PMID: 26093735
Kidney transplantation (KT) is the best available therapy for patients with end-stage renal disease. Infectious complications are a common cause of morbidity and mortality. In this study, we evaluated the...
9.
Celebi Z, Akturk S, Erdogmus S, Kemaloglu B, Toz H, Polat K, et al.
Transplant Proc
. 2015 Jun;
47(5):1269-72.
PMID: 26093696
Background: In Turkey, according to the directions of National Organ and Tissue Transplant Coordination System, a system has been established since 2008 of urgency priority for kidney transplantation in cases...
10.
Tuzuner A, Cakir F, Akyol C, Celebi Z, Ceylaner S, Ceylaner G, et al.
Transplant Proc
. 2013 Apr;
45(3):958-60.
PMID: 23622598
The risk of renal transplanation patients developing de novo malignancy is increased 100-fold compared with the healthy nontransplantation population. Renal cell carcinoma (RCC) arising from native kidneys is diagnosed among...